Grand Brilliance Group Holdings Limited (8372) AI Stock Analysis

• Market Cap: HK$86.40M
• Dividend Yield: 2.29%
• Average Volume (3M): 121.33K
• Price to Earnings (P/E): 9.2
• Beta (1Y): 0.10
• Revenue Growth: 15.32%
• EPS Growth: 20.41%
• Country: HK
• Employees: 50
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Distribution
• EPS (TTM): <0.01
• Shares Outstanding: 800,000,000
• 10 Day Avg. Volume: 87,000
• 30 Day Avg. Volume: 121,333
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 68 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

The overall stock score of 68 reflects strong financial performance and attractive valuation, offset by weak technical indicators. The company's robust balance sheet and reasonable P/E ratio are significant strengths, while the decline in cash flow and bearish technical signals are key concerns.

Grand Brilliance Group Holdings Limited Business Overview & Revenue Model

Company Description

Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.

How the Company Makes Money

Grand Brilliance Group Holdings Limited generates revenue through multiple streams including direct sales of its consumer products, wholesale distribution to retailers, and e-commerce platforms. The company leverages strategic partnerships with suppliers and distributors to enhance its product offerings and market reach. Additionally, Grand Brilliance may engage in licensing agreements and collaborations with other brands to diversify its product range and increase revenue. The company's focus on quality and innovation helps to build customer loyalty, driving repeat sales and contributing to its overall earnings.

Grand Brilliance Group Holdings Limited Financial Statement Overview

Summary

Grand Brilliance Group Holdings Limited demonstrates strong revenue growth and profitability, supported by a robust balance sheet with low leverage. However, the significant decline in free cash flow growth and low operating cash flow coverage ratio highlight potential cash flow management challenges.

Income Statement

Grand Brilliance Group Holdings Limited has shown a consistent revenue growth rate, with a 14.78% increase in the latest year. The gross profit margin has slightly decreased over the years, but the net profit margin has improved to 10.02%. The EBIT and EBITDA margins have remained stable, indicating efficient cost management. However, the decline in gross profit margin from previous years suggests potential pressure on cost control.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.035, indicating low leverage and financial stability. The return on equity has improved to 8.54%, reflecting effective use of equity to generate profits. The equity ratio is healthy, suggesting a strong capital structure. Overall, the balance sheet reflects financial stability and prudent management of liabilities.

Cash Flow

The cash flow statement shows a significant decline in free cash flow growth, down by 87.37% in the latest year, which is a concern. The operating cash flow to net income ratio is low at 0.072, indicating potential challenges in converting income into cash. However, the free cash flow to net income ratio remains strong at 0.87, suggesting that the company can still generate cash relative to its net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	82.29M	94.45M	81.90M	76.70M	71.98M	70.24M
Gross Profit	42.01M	45.72M	41.94M	39.51M	36.35M	33.62M
EBITDA	5.32M	13.95M	13.20M	14.09M	9.87M	12.91M
Net Income	8.45M	9.46M	7.86M	7.56M	4.05M	7.86M
Balance Sheet
Total Assets	116.13M	132.19M	114.50M	115.25M	110.32M	112.01M
Cash, Cash Equivalents and Short-Term Investments	66.48M	60.96M	60.47M	61.86M	55.74M	70.26M
Total Debt	4.20M	3.91M	1.43M	4.45M	4.48M	4.87M
Total Liabilities	11.50M	20.75M	11.22M	16.58M	16.82M	18.96M
Stockholders Equity	104.77M	110.79M	103.33M	98.67M	93.51M	93.05M
Cash Flow
Free Cash Flow	9.28M	1.17M	4.91M	12.60M	-4.12M	5.62M
Operating Cash Flow	10.11M	1.35M	6.72M	12.66M	-3.33M	6.01M
Investing Cash Flow	646.00K	3.77M	-395.00K	-510.00K	-3.96M	-82.00K
Financing Cash Flow	-5.67M	-4.87M	-7.42M	-6.40M	-7.58M	-6.36M

Grand Brilliance Group Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.11
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8372, the sentiment is Negative. The current price of 0.11 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.11, and above the 200-day MA of 0.11, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.72 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8372.

Grand Brilliance Group Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8372	68 Neutral	HK$86.40M	9.24	8.84%	2.29%	15.32%	20.41%
0401	50 Neutral	44.82M	-6.78	-9.89%	―	-10.71%	83.45%
0718	50 Neutral	309.75M	-0.44	43.77%	―	-20.78%	6.78%
0673	45 Neutral	278.03M	-3.92	884.64%	―	-35.02%	-64.05%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%